Paper6206563
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
Levy JA and 5 others. Science, 1984. Cited by 1,295 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Papers, record 6206563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6206563
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Deltaretrovirus | Major topic |
| Homosexuality | Major topic |
| Antibodies, Viral | |
| Bone Marrow | |
| California | |
| Cell Line | |
| Cells, Cultured | |
| Cross Reactions | |
| Cytopathogenic Effect, Viral | |
| Humans | |
| Leukocytes | |
| Lymphatic Diseases | |
| Male | |
| RNA-Directed DNA Polymerase | |
| Syndrome | |
| T-Lymphocytes | |
| Virus Cultivation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA-34980 | NCI NIH HHS | United States | U01CA034980 | PubMed and NIH |
Source NIH RePORTER
Cited by365
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,295 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,661,384 | Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells. | J Virol | 2024 | https://conductscience.org/library/papers/38661384 | PubMed |
| 38,318,650 | Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered. | J Mol Cell Biol | 2024 | https://conductscience.org/library/papers/38318650 | PubMed |
| 37,744,007 | Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer's Disease: Insights from Computational Studies. | Int J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37744007 | PubMed |
| 37,108,826 | TDP-43 Controls HIV-1 Viral Production and Virus Infectiveness. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108826 | PubMed |
| 36,853,052 | Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/36853052 | PubMed |
| 36,539,804 | Thirty-five years (1986-2021) of HIV/AIDS in Nigeria: bibliometric and scoping analysis. | AIDS Res Ther | 2022 | https://conductscience.org/library/papers/36539804 | PubMed |
| 36,172,358 | Non-cytotoxic functions of CD8 T cells: "repentance of a serial killer". | Front Immunol | 2022 | https://conductscience.org/library/papers/36172358 | PubMed |
| 35,832,725 | The involvement of microRNAs in HCV and HIV infection. | Ther Adv Vaccines Immunother | 2022 | https://conductscience.org/library/papers/35832725 | PubMed |
| 35,746,649 | Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs. | Viruses | 2022 | https://conductscience.org/library/papers/35746649 | PubMed |
| 35,712,721 | The Antimicrobial Potential of the Neem Tree Azadirachta indica. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35712721 | PubMed |
| 35,446,679 | Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science. | Physiol Rev | 2022 | https://conductscience.org/library/papers/35446679 | PubMed |
| 34,177,011 | Nano-engineered screen-printed electrodes: A dynamic tool for detection of viruses. | Trends Analyt Chem | 2021 | https://conductscience.org/library/papers/34177011 | PubMed |
| 33,980,586 | The CD8+ T Cell Noncytotoxic Antiviral Responses. | Microbiol Mol Biol Rev | 2021 | https://conductscience.org/library/papers/33980586 | PubMed |
| 33,969,482 | Effects of historical co-infection on host shift abilities of exploitative and competitive viruses. | Evolution | 2021 | https://conductscience.org/library/papers/33969482 | PubMed |
| 33,405,054 | Comparative analysis of differential gene expression of HSP40 and HSP70 family isoforms during heat stress and HIV-1 infection in T-cells. | Cell Stress Chaperones | 2021 | https://conductscience.org/library/papers/33405054 | PubMed |
| 33,142,907 | An Evolutionary Model of Progression to AIDS. | Microorganisms | 2020 | https://conductscience.org/library/papers/33142907 | PubMed |
| 32,375,243 | HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32375243 | PubMed |
| 31,965,427 | Recent Advances in the Development of Integrase Inhibitors for HIV Treatment. | Curr HIV/AIDS Rep | 2020 | https://conductscience.org/library/papers/31965427 | PubMed |
| 31,659,912 | Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death. | AIDS Res Hum Retroviruses | 2020 | https://conductscience.org/library/papers/31659912 | PubMed |
| 31,375,574 | Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression. | J Virol | 2019 | https://conductscience.org/library/papers/31375574 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6206563
GET https://conductscience.org/api/papers/v1/6206563/cited_by?page=2